The name of the child in this story has been changed to protect confidentiality.
Tanya began feeling sick in June 2012. Relatives from Moscow, previously diagnosed with TB, had recently visited Tanya and her family in Moldova. A month later she was diagnosed with TB. In August 2012, one month after being diagnosed with TB, Tanya’s doctor performed drug susceptibility testing. The results showed that Tanya’s strain of TB was resistant to isoniazid, rifampicin, ethambutol, and streptomycin.
By September 2012, Tanya had started receiving treatment with second-line drugs. The treatment placed a significant financial burden on Tanya’s family.
Once on second-line drugs, Tanya’s liver began to show signs of failure. She was quickly taken off of pyrazinamide and put on para-aminosalicylic acid (PAS), and her liver function recovered.
Throughout the course of her treatment, Tanya’s doctor stressed the importance of adhering to treatment by ensuring that Tanya “[understood] her role in completing the treatment.”